Xeomin and Botox are two popular injectable treatments that can help reduce the appearance of wrinkles and lines on the face. However, there are some important differences between these two treatments. Firstly, Xeomin is the newer product and is said to last longer than Botox. Secondly, Xeomin is a single-chain protein, whereas Botox is a double-chain complex. This means that Xeomin has less protein in the solution, potentially resulting in reduced risk of adverse reactions. Lastly, Xeomin is injected differently than Botox; while Botox injections can take place over multiple days, treatments with Xeomin are done at one session, making it a more efficient process. All-in-all, Xeomin and Botox can both provide patients with the desired anti-inflammatory and smoothing effects on the skin through wrinkle reduction. However, determining which one is the best option for an individual patient will require the consultation of a medical expert.
Botox and Xeomin are both cosmetic solutions derived from the same form of botulinum A toxin, a highly beneficial form of a neuromodulator. Botox is an FDA approved treatment for removing wrinkles, lifting eyebrows, reducing excessive sweating, and relieving jaw clenching and TMJ symptoms. Xeomin is a slightly newer product than Botox and is popular in its botulinum A toxin class. Xeomin injectables are largely composed of incobotulinumtoxin Plus A, offering a few advantages over Botox.
One of the most significant differences between Botox and Xeomin is that Botox contains additional protective proteins to ensure precise action. The proteins can sometimes cause an allergic reaction or stinging sensation. Xeomin, however, is void of preservatives and thus, it causes fewer allergic reactions than Botox. Xeomin products, further, require no mixed and are never crossed-linked which makes the muscle relaxation more homogenous.